Evidence map›Paper›PMID 29955181›Full record

ArticleNature medicine2018

Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert and 36 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

46 authors.

Bjoern ChapuyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Chip StewartBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Andrew J DunfordBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Jaegil KimBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Atanas KamburovBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Robert A ReddBiostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Mike S LawrenceHarvard Medical School, Boston, MA, USA.
Margaretha G M RoemerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amy J LiBoston University School of Medicine, Section of Computational Biomedicine, Leipzig, Germany.
Marita ZiepertBoston University School of Medicine, Section of Computational Biomedicine, Leipzig, Germany.
Annette M StaigerDepartment of Clinical Pathology, Robert-Bosch Krankenhaus, Stuttgart, Germany.ORCID http://orcid.org/0000-0002-5896-3200
Jeremiah A WalaBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-6591-1620
Matthew D DucarDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Boston, MA, USA.
Ignaty LeshchinerBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-8942-9265
Ester RheinbayBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Amaro Taylor-WeinerBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Caroline A CoughlinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Julian M HessBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Chandra S PedamalluBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Dimitri LivitzBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2528-1446
Daniel RosebrockBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Mara RosenbergBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Adam A TracyBroad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Heike HornDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Boston, MA, USA.
Paul van HummelenDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Boston, MA, USA.
Andrew L FeldmanMayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5009-4808
Brian K LinkUniversity of Iowa, Iowa City, IA, USA.
Anne J NovakMayo Clinic, Rochester, MN, USA.
James R CerhanMayo Clinic, Rochester, MN, USA.
Thomas M HabermannMayo Clinic, Rochester, MN, USA.
Reiner SiebertDepartment for Human Genetics, University Ulm, Ulm, Germany.
Andreas RosenwaldDepartment of Pathology, University of Würzburg, Würzburg, Germany.
Aaron R ThornerDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Boston, MA, USA.
Matthew L MeyersonHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9133-8108
Todd R GolubHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0113-2403
Rameen BeroukhimHarvard Medical School, Boston, MA, USA.
Gerald G WulfDepartment of Hematology and Oncology, Georg-August University Göttingen, Göttingen, Germany.
German OttDepartment of Clinical Pathology, Robert-Bosch Krankenhaus, Stuttgart, Germany.
Scott J RodigHarvard Medical School, Boston, MA, USA.
Stefano MontiBoston University School of Medicine, Section of Computational Biomedicine, Leipzig, Germany.
Donna S NeubergHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2566-3145
Markus LoefflerBoston University School of Medicine, Section of Computational Biomedicine, Leipzig, Germany.
Michael PfreundschuhDepartment of Medicine I, Saarland University, Homburg, Germany.
Lorenz TrümperDepartment of Hematology and Oncology, Georg-August University Göttingen, Göttingen, Germany.
Gad GetzHarvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.ORCID http://orcid.org/0000-0002-0936-0753
Margaret A ShippDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. margaret_shipp@dfci.harvard.edu.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
6 · The paper itself

Abstract

In the version of this article originally published, some text above the "Tri-nucleotide sequence motifs" label in Fig. 2a appeared incorrectly. The text was garbled and should have appeared as nucleotide codes.Additionally, the labels on the bars in Fig. 2c were not italicized in the original publication. These are gene symbols, and they should have been italicized.The colored labels above the graphs in Fig. 4b were also erroneously not italicized. These labels represent gene names and loci, and they should have been italicized.

Identifiers

PMID29955181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.